Loading…
Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review
The usefulness of anti-Müllerian hormone (AMH) for the quantitative evaluation of ovarian reserve has been established. Therefore, serum AMH has been recently applied to the assessment of ovarian reserve outside infertility treatment. We conducted a computer-based search, using keywords, through the...
Saved in:
Published in: | Reproductive biology and endocrinology 2014-12, Vol.12, p.125-125 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 125 |
container_issue | |
container_start_page | 125 |
container_title | Reproductive biology and endocrinology |
container_volume | 12 |
creator | Iwase, Akira Nakamura, Tomoko Nakahara, Tatsuo Goto, Maki Kikkawa, Fumitaka |
description | The usefulness of anti-Müllerian hormone (AMH) for the quantitative evaluation of ovarian reserve has been established. Therefore, serum AMH has been recently applied to the assessment of ovarian reserve outside infertility treatment. We conducted a computer-based search, using keywords, through the PubMed database from inception until May 2014 and summarized available studies evaluating ovarian damage caused by gynecologic diseases, such as endometriosis and ovarian tumor, as well as surgical interventions, such as cystectomy and uterine artery embolization (UAE), to discuss the usefulness of serum AMH. Most of the studies demonstrated a decline of serum AMH levels after cystectomy for endometriomas. It is not conclusive whether electrocoagulation or suturing is preferable. The effects of other gynecologic diseases and interventions, such as hysterectomy and UAE, on ovarian reserve are controversial. Serum AMH levels should be considered in determining the indication and selection of operative methods for benign gynecologic conditions. |
doi_str_mv | 10.1186/1477-7827-12-125 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4274680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1640330517</sourcerecordid><originalsourceid>FETCH-LOGICAL-p224t-c40c4f7f279a880046835a62938e59ddabbfae62a39f6d4069316dc51caab1ef3</originalsourceid><addsrcrecordid>eNpdkc1O3TAQha1KFVDovqvKUjfdBPwXJ-miEkKFVqJiA-to4kyCkWPf2knQfZi-CTteDEMBtZUs2ZrzzZljDSEfODvkvNZHXFVVUdWiKrjIp3xD9l5Lu-RdSjeMCcZqvUN2RVlyJoXaI7-PU8KUJvQzDQMNK0QLnkZMGFekS7J-pOBnW_y8v3MOn9TrEKfgkTpc0SVqPe3Q29HTcevRBBdGa6gJvrezDT7l_p6mJeYquEzPj9b-SfpCgaZtmnGCOfd4iDE_8uCIq8XbA_J2AJfw_fO9T65Ov12efC_OL85-nByfFxsh1FwYxYwaqkFUDdQ1Y0rXsgQtGllj2fQ9dN0AqAXIZtC9YrqRXPem5Aag4zjIffL1j-9m6SbsTU4XwbWbaCeI2zaAbf9VvL1ux7C2SlR5GMsGn58NYvi1YJrbySaDzoHHsKSWa8WkZCWvMvrpP_QmLNHn72VKNnkvZc0z9fHvRK9RXjYnHwBkvp8s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1639103581</pqid></control><display><type>article</type><title>Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review</title><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Iwase, Akira ; Nakamura, Tomoko ; Nakahara, Tatsuo ; Goto, Maki ; Kikkawa, Fumitaka</creator><creatorcontrib>Iwase, Akira ; Nakamura, Tomoko ; Nakahara, Tatsuo ; Goto, Maki ; Kikkawa, Fumitaka</creatorcontrib><description>The usefulness of anti-Müllerian hormone (AMH) for the quantitative evaluation of ovarian reserve has been established. Therefore, serum AMH has been recently applied to the assessment of ovarian reserve outside infertility treatment. We conducted a computer-based search, using keywords, through the PubMed database from inception until May 2014 and summarized available studies evaluating ovarian damage caused by gynecologic diseases, such as endometriosis and ovarian tumor, as well as surgical interventions, such as cystectomy and uterine artery embolization (UAE), to discuss the usefulness of serum AMH. Most of the studies demonstrated a decline of serum AMH levels after cystectomy for endometriomas. It is not conclusive whether electrocoagulation or suturing is preferable. The effects of other gynecologic diseases and interventions, such as hysterectomy and UAE, on ovarian reserve are controversial. Serum AMH levels should be considered in determining the indication and selection of operative methods for benign gynecologic conditions.</description><identifier>EISSN: 1477-7827</identifier><identifier>DOI: 10.1186/1477-7827-12-125</identifier><identifier>PMID: 25510324</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Age ; Anti-Mullerian Hormone - blood ; Cystectomy ; Cysts ; Endometriosis ; Endometriosis - blood ; Endometriosis - physiopathology ; Endometriosis - surgery ; Female ; Fertility ; Humans ; Hysterectomy ; In vitro fertilization ; Infertility ; Medicine ; Ovarian Neoplasms - blood ; Ovarian Neoplasms - physiopathology ; Ovarian Neoplasms - surgery ; Ovarian Reserve - physiology ; Pregnancy ; Reproductive health ; Review ; Studies ; Surgery ; Tumors ; Uterine Artery Embolization ; Veins & arteries ; Women</subject><ispartof>Reproductive biology and endocrinology, 2014-12, Vol.12, p.125-125</ispartof><rights>2014 Iwase et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Iwase et al.; licensee BioMed Central. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274680/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1639103581?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25510324$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iwase, Akira</creatorcontrib><creatorcontrib>Nakamura, Tomoko</creatorcontrib><creatorcontrib>Nakahara, Tatsuo</creatorcontrib><creatorcontrib>Goto, Maki</creatorcontrib><creatorcontrib>Kikkawa, Fumitaka</creatorcontrib><title>Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review</title><title>Reproductive biology and endocrinology</title><addtitle>Reprod Biol Endocrinol</addtitle><description>The usefulness of anti-Müllerian hormone (AMH) for the quantitative evaluation of ovarian reserve has been established. Therefore, serum AMH has been recently applied to the assessment of ovarian reserve outside infertility treatment. We conducted a computer-based search, using keywords, through the PubMed database from inception until May 2014 and summarized available studies evaluating ovarian damage caused by gynecologic diseases, such as endometriosis and ovarian tumor, as well as surgical interventions, such as cystectomy and uterine artery embolization (UAE), to discuss the usefulness of serum AMH. Most of the studies demonstrated a decline of serum AMH levels after cystectomy for endometriomas. It is not conclusive whether electrocoagulation or suturing is preferable. The effects of other gynecologic diseases and interventions, such as hysterectomy and UAE, on ovarian reserve are controversial. Serum AMH levels should be considered in determining the indication and selection of operative methods for benign gynecologic conditions.</description><subject>Age</subject><subject>Anti-Mullerian Hormone - blood</subject><subject>Cystectomy</subject><subject>Cysts</subject><subject>Endometriosis</subject><subject>Endometriosis - blood</subject><subject>Endometriosis - physiopathology</subject><subject>Endometriosis - surgery</subject><subject>Female</subject><subject>Fertility</subject><subject>Humans</subject><subject>Hysterectomy</subject><subject>In vitro fertilization</subject><subject>Infertility</subject><subject>Medicine</subject><subject>Ovarian Neoplasms - blood</subject><subject>Ovarian Neoplasms - physiopathology</subject><subject>Ovarian Neoplasms - surgery</subject><subject>Ovarian Reserve - physiology</subject><subject>Pregnancy</subject><subject>Reproductive health</subject><subject>Review</subject><subject>Studies</subject><subject>Surgery</subject><subject>Tumors</subject><subject>Uterine Artery Embolization</subject><subject>Veins & arteries</subject><subject>Women</subject><issn>1477-7827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkc1O3TAQha1KFVDovqvKUjfdBPwXJ-miEkKFVqJiA-to4kyCkWPf2knQfZi-CTteDEMBtZUs2ZrzzZljDSEfODvkvNZHXFVVUdWiKrjIp3xD9l5Lu-RdSjeMCcZqvUN2RVlyJoXaI7-PU8KUJvQzDQMNK0QLnkZMGFekS7J-pOBnW_y8v3MOn9TrEKfgkTpc0SVqPe3Q29HTcevRBBdGa6gJvrezDT7l_p6mJeYquEzPj9b-SfpCgaZtmnGCOfd4iDE_8uCIq8XbA_J2AJfw_fO9T65Ov12efC_OL85-nByfFxsh1FwYxYwaqkFUDdQ1Y0rXsgQtGllj2fQ9dN0AqAXIZtC9YrqRXPem5Aag4zjIffL1j-9m6SbsTU4XwbWbaCeI2zaAbf9VvL1ux7C2SlR5GMsGn58NYvi1YJrbySaDzoHHsKSWa8WkZCWvMvrpP_QmLNHn72VKNnkvZc0z9fHvRK9RXjYnHwBkvp8s</recordid><startdate>20141215</startdate><enddate>20141215</enddate><creator>Iwase, Akira</creator><creator>Nakamura, Tomoko</creator><creator>Nakahara, Tatsuo</creator><creator>Goto, Maki</creator><creator>Kikkawa, Fumitaka</creator><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7QG</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20141215</creationdate><title>Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review</title><author>Iwase, Akira ; Nakamura, Tomoko ; Nakahara, Tatsuo ; Goto, Maki ; Kikkawa, Fumitaka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p224t-c40c4f7f279a880046835a62938e59ddabbfae62a39f6d4069316dc51caab1ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Age</topic><topic>Anti-Mullerian Hormone - blood</topic><topic>Cystectomy</topic><topic>Cysts</topic><topic>Endometriosis</topic><topic>Endometriosis - blood</topic><topic>Endometriosis - physiopathology</topic><topic>Endometriosis - surgery</topic><topic>Female</topic><topic>Fertility</topic><topic>Humans</topic><topic>Hysterectomy</topic><topic>In vitro fertilization</topic><topic>Infertility</topic><topic>Medicine</topic><topic>Ovarian Neoplasms - blood</topic><topic>Ovarian Neoplasms - physiopathology</topic><topic>Ovarian Neoplasms - surgery</topic><topic>Ovarian Reserve - physiology</topic><topic>Pregnancy</topic><topic>Reproductive health</topic><topic>Review</topic><topic>Studies</topic><topic>Surgery</topic><topic>Tumors</topic><topic>Uterine Artery Embolization</topic><topic>Veins & arteries</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iwase, Akira</creatorcontrib><creatorcontrib>Nakamura, Tomoko</creatorcontrib><creatorcontrib>Nakahara, Tatsuo</creatorcontrib><creatorcontrib>Goto, Maki</creatorcontrib><creatorcontrib>Kikkawa, Fumitaka</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Reproductive biology and endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iwase, Akira</au><au>Nakamura, Tomoko</au><au>Nakahara, Tatsuo</au><au>Goto, Maki</au><au>Kikkawa, Fumitaka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review</atitle><jtitle>Reproductive biology and endocrinology</jtitle><addtitle>Reprod Biol Endocrinol</addtitle><date>2014-12-15</date><risdate>2014</risdate><volume>12</volume><spage>125</spage><epage>125</epage><pages>125-125</pages><eissn>1477-7827</eissn><abstract>The usefulness of anti-Müllerian hormone (AMH) for the quantitative evaluation of ovarian reserve has been established. Therefore, serum AMH has been recently applied to the assessment of ovarian reserve outside infertility treatment. We conducted a computer-based search, using keywords, through the PubMed database from inception until May 2014 and summarized available studies evaluating ovarian damage caused by gynecologic diseases, such as endometriosis and ovarian tumor, as well as surgical interventions, such as cystectomy and uterine artery embolization (UAE), to discuss the usefulness of serum AMH. Most of the studies demonstrated a decline of serum AMH levels after cystectomy for endometriomas. It is not conclusive whether electrocoagulation or suturing is preferable. The effects of other gynecologic diseases and interventions, such as hysterectomy and UAE, on ovarian reserve are controversial. Serum AMH levels should be considered in determining the indication and selection of operative methods for benign gynecologic conditions.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>25510324</pmid><doi>10.1186/1477-7827-12-125</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1477-7827 |
ispartof | Reproductive biology and endocrinology, 2014-12, Vol.12, p.125-125 |
issn | 1477-7827 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4274680 |
source | PMC (PubMed Central); Publicly Available Content (ProQuest) |
subjects | Age Anti-Mullerian Hormone - blood Cystectomy Cysts Endometriosis Endometriosis - blood Endometriosis - physiopathology Endometriosis - surgery Female Fertility Humans Hysterectomy In vitro fertilization Infertility Medicine Ovarian Neoplasms - blood Ovarian Neoplasms - physiopathology Ovarian Neoplasms - surgery Ovarian Reserve - physiology Pregnancy Reproductive health Review Studies Surgery Tumors Uterine Artery Embolization Veins & arteries Women |
title | Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A50%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20ovarian%20reserve%20using%20anti-M%C3%BCllerian%20hormone%20levels%20in%20benign%20gynecologic%20conditions%20and%20surgical%20interventions:%20a%20systematic%20narrative%20review&rft.jtitle=Reproductive%20biology%20and%20endocrinology&rft.au=Iwase,%20Akira&rft.date=2014-12-15&rft.volume=12&rft.spage=125&rft.epage=125&rft.pages=125-125&rft.eissn=1477-7827&rft_id=info:doi/10.1186/1477-7827-12-125&rft_dat=%3Cproquest_pubme%3E1640330517%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p224t-c40c4f7f279a880046835a62938e59ddabbfae62a39f6d4069316dc51caab1ef3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1639103581&rft_id=info:pmid/25510324&rfr_iscdi=true |